Conditions: Uveitis
Keywords: uveitis apremilast
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 3
Healthy volunteers: no

Brief summary:
The purpose of this study is to assess the safety and efficacy of Apremilast in the treatment of uveitis.

Detailed description:

Arms:
arm 1: Patients receiving apremilast.

Interventions: intervention 1: Apremilast
Intervention descriptions: intervention 1: oral dose of 30 mg BID for 6 months

Protocol document: